Literature DB >> 2138526

Sensitive enzyme immunoassay for human Cu/Zn superoxide dismutase.

N Kurobe1, F Suzuki, K Okajima, K Kato.   

Abstract

A highly sensitive enzyme immunoassay method for measurement of human Cu/Zn superoxide dismutase (SOD) was established. Antisera were raised in rabbits by injecting SOD purified from human erythrocytes, and antibodies to SOD were purified by the use of Cu/Zn SOD-coupled Sepharose 4B. The assay system consisted of polystyrene balls with immobilized monospecific antibody F(ab')2 fragments and the same antibody Fab' fragments labeled with beta-D-galactosidase from Escherichia coli. The assay was highly sensitive, and the minimum detection limit was 3 pg or 0.1 fmol/assay tube. Serum Cu/Zn SOD levels of normal healthy subjects (36.3 +/- 15.6, n = 120, 16-64 years old) were not related to age and sex. It was confirmed that Cu/Zn SOD levels in erythrocytes and blood plasma were significantly enhanced in patients with Down syndrome. Immunoreactive Cu/Zn SOD was detectable in all the tissues examined and was present at high concentrations in brain, adrenal gland, liver, heart and kidney.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138526     DOI: 10.1016/0009-8981(90)90257-s

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  14 in total

1.  A common property of amyotrophic lateral sclerosis-associated variants: destabilization of the copper/zinc superoxide dismutase electrostatic loop.

Authors:  Kathleen S Molnar; N Murat Karabacak; Joshua L Johnson; Qi Wang; Ashutosh Tiwari; Lawrence J Hayward; Stephen J Coales; Yoshitomo Hamuro; Jeffrey N Agar
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

2.  Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice.

Authors:  Barry Gertz; Margaret Wong; Lee J Martin
Journal:  J Neuropathol Exp Neurol       Date:  2012-02       Impact factor: 3.685

3.  Molecular indices of neuronal and glial plasticity in the hippocampal formation in a rodent model of age-induced spatial learning impairment.

Authors:  K Sugaya; M Chouinard; R Greene; M Robbins; D Personett; C Kent; M Gallagher; M McKinney
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

Review 4.  Posttranslational modifications in Cu,Zn-superoxide dismutase and mutations associated with amyotrophic lateral sclerosis.

Authors:  Yoshiaki Furukawa; Thomas V O'Halloran
Journal:  Antioxid Redox Signal       Date:  2006 May-Jun       Impact factor: 8.401

5.  Enhancement of S-100 beta protein in blood of patients with Down's syndrome.

Authors:  K Kato; F Suzuki; N Kurobe; K Okajima; N Ogasawara; M Nagaya; T Yamanaka
Journal:  J Mol Neurosci       Date:  1990       Impact factor: 3.444

6.  Modifications of superoxide dismutase (SOD1) in human erythrocytes: a possible role in amyotrophic lateral sclerosis.

Authors:  Kyle C Wilcox; Li Zhou; Joshua K Jordon; Yi Huang; Yanbao Yu; Rachel L Redler; Xian Chen; Michael Caplow; Nikolay V Dokholyan
Journal:  J Biol Chem       Date:  2009-03-19       Impact factor: 5.157

Review 7.  Aggregation of copper-zinc superoxide dismutase in familial and sporadic ALS.

Authors:  Madhuri Chattopadhyay; Joan Selverstone Valentine
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

8.  Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: a possible general mechanism for familial ALS.

Authors:  Lucia Banci; Ivano Bertini; Armando Durazo; Stefania Girotto; Edith Butler Gralla; Manuele Martinelli; Joan Selverstone Valentine; Miguela Vieru; Julian P Whitelegge
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

9.  Concentrations of several proteins characteristic of nervous tissue in cerebral cortex of patients with Alzheimer's disease.

Authors:  K Kato; N Kurobe; F Suzuki; R Morishita; T Asano; T Sato; T Inagaki
Journal:  J Mol Neurosci       Date:  1991       Impact factor: 3.444

Review 10.  SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration.

Authors:  Pamela Milani; Giulia Ambrosi; Omar Gammoh; Fabio Blandini; Cristina Cereda
Journal:  Oxid Med Cell Longev       Date:  2013-07-28       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.